0001209191-22-048720.txt : 20220906 0001209191-22-048720.hdr.sgml : 20220906 20220906161129 ACCESSION NUMBER: 0001209191-22-048720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220906 DATE AS OF CHANGE: 20220906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rice David William CENTRAL INDEX KEY: 0001932923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56424 FILM NUMBER: 221228381 MAIL ADDRESS: STREET 1: C/O LIFE360, INC. STREET 2: 539 BRYANT STREET, SUITE 402 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Life360, Inc. CENTRAL INDEX KEY: 0001581760 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 539 BRYANT STREET, SUITE 402 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-462-0002 MAIL ADDRESS: STREET 1: 539 BRYANT STREET, SUITE 402 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-01 0 0001581760 Life360, Inc. 360.AX 0001932923 Rice David William C/O LIFE360, INC. 539 BRYANT STREET, SUITE 402 SAN FRANCISCO CA 94107 0 1 0 0 Chief Operating Officer Common Stock 2022-09-01 4 S 0 12962 9.9976 D 379870 D This reported sale was executed on the Australian Securities Exchange (the "ASX") as Chess Depositary Interests ("CDIs") and sold using Australian Dollars. The CDIs are traded on the ASX and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Represents shares of the Issuer's common stock underlying 38,886 CDIs. Prices in this Form 4 are expressed in United States Dollars using the conversion rate on September 1, 2022. The reported sale price in Column 4 is a weighted average price. These shares were sold in multiple transactions. Prices ranged from $9.9813 to $10.0832 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 317,570 shares of the Issuer's common stock underlying 952,710 CDIs. Also includes 62,300 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. /s/ Daniel Menudier, as Attorney-in-Fact 2022-09-06